Welcome to LookChem.com Sign In|Join Free
  • or
(1S,2S)-N-(1-isobutyl-3-chloro-2-hydroxypropyl)benzyloxycarbonylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

159141-66-9

Post Buying Request

159141-66-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

159141-66-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 159141-66-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,1,4 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 159141-66:
(8*1)+(7*5)+(6*9)+(5*1)+(4*4)+(3*1)+(2*6)+(1*6)=139
139 % 10 = 9
So 159141-66-9 is a valid CAS Registry Number.

159141-66-9Downstream Products

159141-66-9Relevant academic research and scientific papers

Asymmetric transfer hydrogenation of α-aminoalkyl α′-chloromethyl ketones with chiral Rh complexes

Hamada, Takayuki,Torii, Takayoshi,Onishi, Tomoyuki,Izawa, Kunisuke,Ikariya, Takao

, p. 7391 - 7394 (2007/10/03)

Asymmetric transfer hydrogenation of N-substituted (3S)-3-amino-1-chloro-4- phenyl-2-butanones in the presence of Cp*RhCl[(R,R)-Tsdpen] (S/C = 1000) with a mixture of formic acid/triethylamine gave N-substituted (2R,3S)-3-amino-1-chloro-2-hydroxy-4-phenylbutanes with up to 93% de in a quantitative yield, and reduction with the enantiomeric catalyst Cp*RhCl[(S,S)-Tsdpen] gave (2S.3S)-diastereomeric alcohol with up to 96% de.

Sulfonamide inhibitors of aspartyl protease

-

Example 196, (2008/06/13)

The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.

Stereocontrolled synthesis of erythro N-protected α-amino epoxides and peptidyl epoxides

Albeck, Amnon,Persky, Rachel

, p. 6333 - 6346 (2007/10/02)

N-protected α-amino epoxides of erythro configuration, derived from α-amino acids, were synthesized in a stereoselective manner. The erythro (2S,3S), configuration was achieved by the synthetic sequence: amino acid -> haloketone -> halohydrin -> epoxide. A mechanistic explanation for the observed stereoselectivity is presented. This stereoselective synthetic approach was applied to the synthesis of a variety of short peptidyl epoxides, bearing a predefined absolute configuration of the chiral epoxide moiety.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 159141-66-9